Welcome to our dedicated page for Camtek SEC filings (Ticker: CAMT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Camtek Ltd (CAMT) SEC filings page on Stock Titan aggregates the company’s U.S. regulatory disclosures as a foreign private issuer. Camtek files an Annual Report on Form 20-F and furnishes interim information on Form 6-K, including press releases, unaudited financial statements, and operating and financial review documents. These filings provide detailed insight into its business as a developer and manufacturer of high-end inspection and metrology equipment for the semiconductor industry.
Through recent Form 6-K reports, investors can review Camtek’s quarterly and year-to-date financial results, including GAAP and non-GAAP figures, segment commentary, and management discussion of drivers such as advanced packaging, Memory and HBM, and high-performance computing for AI applications. The company also explains its use of non-GAAP measures that exclude share-based compensation, acquisition-related expenses, and, in some periods, expenses related to the extinguishment of convertible notes.
Filings further document Camtek’s capital structure activity. A Form 6-K dated September 16, 2025, describes the closing of an aggregate $500 million principal amount of 0.00% Convertible Senior Notes due 2030, issued under an indenture and positioned as senior unsecured obligations. The filing outlines key terms such as maturity, conversion mechanics, redemption and repurchase provisions, and the intended use of proceeds, including repurchase of existing 0% convertible notes due 2026 and general corporate purposes.
On Stock Titan, these SEC documents are paired with AI-powered tools that help readers navigate complex items such as Form 6-K exhibits, indenture summaries, and reconciliations between GAAP and non-GAAP performance. Users can quickly locate quarterly results, capital markets transactions, and risk factor discussions that Camtek references in its filings without reading every line of each report.
Form 144 notice for Camtek Ltd (CAMT) reporting a proposed sale of 4,018 ordinary shares through Oppenheimer & Co. Inc. on or about 08/22/2025 with an aggregate market value of $328,431.32. The filing lists the acquisition history for the securities sold: a mix of performance stock units and restricted stock units acquired on 04/28/2021, 01/24/2022 and 01/16/2023, totaling the reported shares. The filer certifies no undisclosed material adverse information. The notice contains no prior sales in the past three months.
Form 144 notice for Camtek Ltd (CAMT) shows a proposed sale of 8,504 ordinary shares through Oppenheimer & Co. Inc. on or about 08/14/2025 with an aggregate market value of $749,457.52. The filing lists the acquisition details for those shares: a mix of performance share units (PSUs) and restricted stock units granted by the issuer between 04/28/2021 and 01/16/2023, totaling the reported units by grant date and type. The filing states there were no securities sold by the reporting person in the past three months. The filer affirms no undisclosed material adverse information and includes the standard signature statement regarding accuracy.
Wasatch Advisors LP reports beneficial ownership of 3,529,165 ordinary shares of Camtek Ltd, representing 7.7% of the class. The filing shows Wasatch has sole dispositive power over 3,506,727 shares and reports no shared voting or dispositive power. The document contains two different figures for sole voting power in separate sections (2,458,296 and 2,485,296), which are presented as reported and are not reconciled within the filing.
The filing is submitted as a Schedule 13G/A by an investment adviser (Type IA) and includes a certification that the holdings were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.
Camtek Ltd (CAMT) submitted a Form 144 notice reporting a proposed sale of 21,321 ordinary shares through Oppenheimer & Co. Inc., with an aggregate market value of $1,844,906.13. The sale is scheduled approximately for 08/13/2025 and the shares are listed on Nasdaq. The form states the issuer has 45,449,306 shares outstanding, providing context for the transaction size.
The securities to be sold were acquired as restricted stock units from the issuer on 04/28/2021 (2,774 shares), 01/24/2022 (4,637 shares), and 01/16/2023 (13,910 shares), which together equal the 21,321 shares offered. The filing reports no securities sold in the past three months and includes the seller's standard representation that they are unaware of any undisclosed material adverse information; a trading-plan reference is noted but no plan adoption date is provided.
Camtek Ltd (CAMT) Form 144 filing discloses that an unidentified insider intends to sell 7,300 ordinary shares through broker Oppenheimer & Co. The planned transaction, scheduled on or about 08-07-2025, carries an aggregate market value of $594,147, based on the prevailing market price when the notice was prepared.
The shares represent roughly 0.016 % of Camtek’s 45.45 million shares outstanding, implying a modest dilution impact. The stock to be sold derives from previously granted restricted stock units (RSUs) acquired on 09-24-2020 (6,500 shares) and 08-18-2021 (800 shares). No shares were sold by the filer in the past three months, and the signer affirms possession of no undisclosed material adverse information.
While the filing is routine and compliant with Rule 144, it signals a limited insider disposition that investors may interpret as a marginally negative sentiment check rather than a material event for the company’s fundamentals.